Compare Jones Lang LaSalle Inc (JLL) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jones Lang LaSalle Inc vs Tenet Healthcare Corporation — how do they compare? Jones Lang LaSalle Inc trades at $325.29 (market cap $15.12B), while Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B). The key difference: Jones Lang LaSalle Inc and Tenet Healthcare Corporation are close in size by market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals.
| JLL | THC | |
|---|---|---|
Market Cap | $15.12B | $16.74B |
Sector | Real Estate | Health |
52-Week High | $358.66 | $244.80 |
52-Week Low | $253.48 | $148.38 |
Enterprise Value | $18.66B | $26.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JLL trades at $324.44, down 1.88% today, with a bullish technical signal from moving averages and a consensus price target of $405.50 suggesting 25% upside. Recent quarters show consistent earnings beats, with Q1 2026 EPS of $3.43 exceeding the $3.01 estimate. Revenue grew to $26.12B in 2025, and net income margin improved to 3.03%. Positive news highlights AI-driven real estate demand and major financing deals, reinforcing growth prospects.
The outlook for JLL is positive, supported by strong fundamentals, analyst upgrades, and strategic positioning in AI-impacted real estate markets. Key opportunities include continued earnings momentum and valuation upside, while risks involve economic sensitivity and competitive pressures in commercial real estate services.
Tenet Healthcare (THC) trades at $194.38, down 0.27% on the day, with a bearish technical signal but strong fundamentals. The stock has beaten EPS estimates for three consecutive quarters, with a Q2 2026 report due July 24. Valuation metrics appear attractive with a P/E of 10.11 and P/S of 0.79. Revenue and net income are projected to grow in 2026, supported by expansion in outpatient care.
The outlook is positive given analyst consensus with 81% buy ratings and a $234.63 price target, implying 21% upside. Risks include potential pressure from lower patient days and high debt levels. Earnings growth and ambulatory care performance remain key catalysts for near-term momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
